Radiotherapy for geriatric head-and-neck cancer patients: what is the value of standard treatment in the elderly?

Схожие документы

• The value of moderate dose escalation for re-irradiation of recurrent or second primary head-and-neck cancer
  по: Alexander Rühle, et al.
  Опубликовано: (2020-04-01)
• The value of moderate dose escalation for re-irradiation of recurrent or second primary head-and-neck cancer
  по: Rühle, Alexander, et al.
  Опубликовано: (2020)
• Surviving Elderly Patients with Head-and-Neck Squamous Cell Carcinoma—What Is the Long-Term Quality of Life after Curative Radiotherapy?
  по: Rühle, Alexander, et al.
  Опубликовано: (2021)
• The Value of Laboratory Parameters for Anemia, Renal Function, Systemic Inflammation and Nutritional Status as Predictors for Outcome in Elderly Patients with Head-and-Neck Cancers
  по: Rühle, Alexander, et al.
  Опубликовано: (2020)
• Radiation-induced toxicities and outcomes after radiotherapy are independent of patient age in elderly salivary gland cancer patients: results from a matched-pair analysis of a rare disease
  по: Rühle, Alexander, et al.
  Опубликовано: (2020)